000 | 00904 a2200313 4500 | ||
---|---|---|---|
005 | 20250514141457.0 | ||
264 | 0 | _c19961201 | |
008 | 199612s 0 0 spa d | ||
022 | _a0366-7170 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHERRERAMALMSTEN, L | |
245 | 0 | 0 |
_a[EXPERIMENTAL STUDY OF RIFAMYCIN SV. (PRELIMINARY REPORT)]. _h[electronic resource] |
260 |
_bChemotherapia _c |
||
300 |
_a621-35 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAminosalicylic Acid |
650 | 0 | 4 | _aAminosalicylic Acids |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 | _aIsoniazid |
650 | 0 | 4 | _aResearch |
650 | 0 | 4 | _aRifamycins |
650 | 0 | 4 | _aStreptomycin |
650 | 0 | 4 | _aTuberculosis |
700 | 1 | _aBORRASCUESTA, F | |
700 | 1 | _aHERRERACARVAJAL, C | |
773 | 0 |
_tChemotherapia _gvol. 10 _gp. 621-35 |
|
999 |
_c13946754 _d13946754 |